Toxin production by Burkholderia pseudomallei strains and correlation with severity of melioidosis

Journal of Medical Microbiology

Volumn 46, Issue 7, 1997, Pages 557-563

  Haase, Antje ^a   Janzen, Julia ^a   Barrett, Siobhan ^a   Currie, B ^b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; DNA; EXOTOXIN;

ANIMAL DISEASE; ARTICLE; BACTERIUM ISOLATION; BURKHOLDERIA PSEUDOMALLEI; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; ENCEPHALITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOBLOTTING; MELIOIDOSIS; NONHUMAN; PNEUMONIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SOIL MICROFLORA;

EID: 0030877412     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-46-7-557     Document Type: Article

References (28)

1. Merianos A, Patel M, Lane JM et al. The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health 1993; 24: 425-435.
2. Currie B, Howard D, Nguyen VT, Withnall K, Merianos A. The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: clinical aspects. Southeast Asian J Trop Med Public Health 1993; 24: 436-443.
3. Kanai K, Kondo E. Recent advances in biomedical sciences of Burkholderia pseudomallei (basonym: Pseudomonas pseudomallei). Jpn J Med Sci Biol 1994; 47: 1-45.
4. Chaowagul W, White NJ, Dance DAB et al. Melioidosis: a major cause of community-acquired septicemia in northern Thailand. J Infect Dis 1989; 159: 890-899.
5. Mays EE, Ricketts EA. Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure. Chest 1975; 68: 261-263.
6. Haase A, Melder A, Smith-Vaughan U, Kemp D, Currie B. RAPD analysis of isolates of Burkholderia pseudomallei from patients with recurrent melioidosis. Epidemiol Infect 1995; 115: 115-121.
7. Chaowagul W, Supputtamongkol Y, Dance DA, Rajchanuvong A, Pattara-arechachai J, White NJ. Relapse in melioidosis: incidence and risk factors. J Infect Dis 1993; 168: 1181-1185.
8. Woods ML, Currie BJ, Howard DM et al. Neurological melioidosis: seven cases from the Northern Territory of Australia. Clin Infect Dis 1992; 15: 163-169.
9. Heckly RJ, Nigg C. Toxins of Pseudomonas pseudomallei II. Characterization. J Bacteriol 1958; 76: 427-436.
10. Heckly RJ. Differentiation of exotoxin and other biologically active substances in Pseudomonas pseudomallei filtrates. J Bacteriol 1964; 88: 1730-1736.
11. Sexton MM, Jones AL, Chaowagul W, Woods DE. Purification and characterization of a protease from Pseudomonas pseudomallei. Can J Microbiol 1994; 40: 903-910.
12. Mohamed R, Nathan S, Embi N, Razak N, Ismail G. Inhibition of macromolecular synthesis in cultured macrophages by Pseudomonas pseudomallei exotoxin. Microbiol Immunol 1989; 33: 811-820.
13. Ismail G, Noor Embi N, Omar O, Allen JC, Smith CJ. A competitive immunosorbent assay for detection of Pseudomonas pseudomallei exotoxin. J Med Microbiol 1987; 23: 353-357.
14. Haase A, Smith-Vaughan H, Melder A et al. Subdivision of Burkholderia pseudomallei into multiple types by random amplified polymorphic DNA analysis provides new insights into epidemiology. J Clin Microbiol 1995; 33: 1687-1690.
15. Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994; 62: 244-251.
16. Okuda J, Kurazono H, Takeda Y. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb Pathog 1995; 18: 167-172.
17. Pickett CL, Cottle DL, Pesci EC, Bikah G. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Inject Immun 1994; 62: 1046-1051.
18. Bag PK, Ramamurthy T, Nair UB. Evidence for the presence of a receptor for the cytolethal distending toxin (CLDT) of Camplyobacter jejuni on CHO and HeLa cell membranes and development of a receptor-based enzyme-linked immunosorbent assay for detection of CLDT. FEMS Microbiol Lett 1993; 114: 285-291.
19. Kothary MH, Claverie EF, Miliotis MD, Madden JM, Richardson SH. Purification and characterization of a Chinese hamster ovary cell elongation factor of Vibrio hollisae. Infect Immun 1995; 63: 2418-2423.
20. Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog 1988; 4: 115-126.
21. Middlebrook JL, Dorland RB. Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity. Can J Microbiol 1977; 23: 183-189.
22. Gray GL, Smith DH, Baldridge JS et al. Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 1984; 81: 2645-2649.
23. Blanke SR, Huang K, Wilson BA, Papini E, Covacci A, Collier RJ. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2. Biochemistry 1994; 33: 5155-5161.
24. Taichman NS, Iwase M, Lally ET, Shattil SJ, Cunningham ME, Korchak HM. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells. J Immunol 1991; 147: 3587-3594.
25. Dreyfus LA, Harville B, Howard DE, Shaban R, Beatty DM, Morris SJ. Calcium influx mediated by the Escherichia coli heat-stable enterotoxin B (STB). Proc Natl Acad Sci USA 1993; 90: 3202-3206.
26. Thomas AD, Forbes-Faulkner J, Parker M. Isolation of Pseudomonas pseudomallei from clay layers at definite depths. Am J Epidemiol 1979; 110: 515-521.
27. Jones AL, Beveridge TJ, Woods DE. Intracellular survival of Burkholderia pseudomallei. Infect Immun 1996; 64: 782-790.
28. Anderson JD, MacNab AJ, Gransden WR, Damm SM, Johnson WM, Lior H. Gastroenteritis and encephalopathy associated with a strain of Escherichia coli O55 K59:H4 that produced a cytolethal distending toxin. Pediatr Infect Dis J 1987; 6: 1135-1136.